Skip to main content
. 2006 Oct 16;51(1):40–47. doi: 10.1128/AAC.01072-06

TABLE 1.

Clinical characteristics, serotypes, PFGE profiles, and STs of international PNSP clones

Pneumococcal clone STa Allelic profilea,b Serotype PFGE type(s) No. of isolates Site(s) of isolationc,d Yr of isolation pbp profilee MIC (μg/ml)f
PEN AMX CXM CRO FEP MEM
Spain23F-1 81 4-4-2-4-4-1-1 23F 1a 1-1-1
81 4-4-2-4-4-1-1 23F 1a, f, g, h, j, k, l, m, n, o, p, 2 20 Sputum, BAL, CSF, blood 1997-2002 1-1-1 2 1 4 1 1 0.5
81 4-4-2-4-4-1-1 19A 1d 1 BAL 1997 1-1-1 2 2 8 2 1 1
81 4-4-2-4-4-1-1 19F 1b, c 2 Sputum 1995, 2002 1-1-1 2 2 4-8 1 1 0.5
1051 4-4-2-4-53-1-1 23F 1i 1 Sputum 1999 1-1-1 2 1 4 1 1 0.5
1476 4-4-2-4-104-1-1 23F 1f 1 Sputum 1998 1-1-1 2 2 8 1 1 0.5
Spain6B-2 90 5-5-1-2-6-3-4 6B 3a 1-2-other
90 5-5-1-2-6-3-4 6B 3a, b 3 CSF, sputum 1999, 2001 1-2-2 2 1 4-8 1 1 0.5
Spain9V-3 156 7-11-10-1-6-8-1 9V 4a 1-1-1
156 7-11-10-1-6-8-1 9V 4a, b, e, f, g, h, i 18 Sputum, BAL, CSF, sinus 1995, 1999, 2000-2002 1-1-1 2 0.5-2 2-8 0.5-1 0.5-1 0.25-0.5
156 7-11-10-1-6-8-1 9V 4h 1 CSF 2002 2-1-1 1 1 4 0.5 0.5 0.5
156 7-11-10-1-6-8-1 14 4b, c, d, e 4 Sputum, CSF 2000, 2002 1-1-1 2 1 4-16 1-2 1 0.5
156 7-11-10-1-6-8-1 Rough 5 1 Sputum 2002 1-1-1 2 1 8 1 1 0.25
557 7-11-10-1-6-58-1 9V 4e 1 CSF 2000 1-1-1 2 1 2 0.5 0.5 0.5
Taiwan23F-15 242 15-29-4-21-30-1-14 23F 7 3-1-3
242 15-29-4-21-30-1-14 23F 7 1 Sputum 2000 3-1-3 4 2 8 2 1 0.5
242 15-29-4-21-30-1-14 23F 8 1 Blood 2002 3-3-3 4 4 8 2 1 1
Poland23F-16 173 7-13-8-1-10-6-36 23F 9 4-1-4
173 7-13-8-1-10-6-36 23F 9 1 Blood 1998 4-1-4 4 2 16 2 1 0.5
173 7-13-8-1-10-6-36 23F 10c 1 CSF 1997 4-4-4 8 2 4 0.5 2 0.5
173 7-13-8-1-10-6-36 23F 10d 1 BAL 1997 4-5-5 8 16 >32 4 8 0.5
272 7-13-8-1-10-6-37 23F 11a 3 BAL, sputum 2000 4-6-5 8 8-16 ≥32 2-4 1-2 0.5
272 7-13-8-1-10-6-37 23F 11e, f 3 BAL, eye, sputum 1998, 2000 4-7-5 8 8 4-16 1-2 1 0.25
272 7-13-8-1-10-6-37 23F 11b, c, d 3 CSF, blood 2002 4-8-5 4-8 8 32 2-4 1 0.5
1482 7-13-8-1-100-6-36 23F 10a 1 Eye 1997 5-4-4 0.5 0.25 1 0.25 0.25 0.06
1506 7-13-8-1-10-6-162 23F 10b 1 BAL 1997 4-4-6 4 4 2 0.25 1 0.25
Poland6B-20 315 20-28-1-1-15-14-14 6B 12a WT-9-WT
315 20-28-1-1-15-14-14 6B 12a, d, g 14 Sputum, ear, blood, BAL, CSF 1995-1996, 1998, 2001-2002 WT-9-WT 0.12 0.06-0.12 0.12-0.25 0.06 0.06-0.12 0.06
315 20-28-1-1-15-14-14 6B 13 1 Sputum 1998 6-10-WT 2 1 2 0.25 1 0.25
315 20-28-1-1-15-14-14 6B 12a 2 Sputum, sinus 1999, 2001 7-11-WT 0.5 0.25 0.25 0.25 0.25 0.12
315 20-28-1-1-15-14-14 6B 12c, e 2 Ear, sputum 1995 NT-7-3 2 1-2 2 1 1 0.25
316 1-28-1-1-15-14-14 6B 12b 1 Blood 1998 WT-9-WT 0.12 0.12 0.12 0.06 0.06 0.06
606 16-28-1-1-15-14-14 6B 12d 1 CSF 1998 WT-9-WT 0.12 0.12 0.06 0.06 0.06
1032 20-28-1-1-6-14-14 6B 12h, i 2 Sputum 2001 WT-9-WT 0.12 0.12 0.12 0.06 0.06 0.06
1052 20-28-1-8-15-14-14 6B 12f 1 Pleural fluid 1996 WT-9-WT 0.12 0.12 0.06 0.06 0.06
1505 20-28-1-1-105-14-14 6B 12b 1 Sputum 2002 WT-9-WT 0.12 0.12 0.12 0.06 0.06 0.06
Sweden15A-25 63 2-5-36-12-17-21-14 15A 14 Other-12-4
63 2-5-36-12-17-21-14 15A 14 1 Sputum 1999 8-12-4 0.25 ≤0.03 0.12 0.06 0.06 ≤0.03
a

New STs and alleles are underlined.

b

In the order aroE-gdh-gki-recP-spi-xpt-ddl.

c

BAL, bronchoalveolar lavage; CSF, cerebrospinal fluid.

d

Susceptibilities, serotypes, and STs of meningitis-related isolates were described in reference 39, and ciprofloxacin-nonsusceptible isolates (single isolates of ST81, ST276, and ST1477 and two isolates of ST156) were described in reference 38.

e

In the order pbp1a-pbp2x-pbp2b. NT, nontypeable; other, pattern unique to an ATCC clone.

f

PEN, penicillin; AMX, amoxicillin; CXM, cefuroxime; CRO, ceftriaxone; FEP, cefepime; MEM, meropenem.